NCT00143351 - Mozart Relapse Study | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

June 30, 2003

Study Completion Date

September 30, 2005

Conditions

Schizophrenia

Interventions

DRUG

Ziprasidone

Trial Locations (16)

10126

Pfizer Investigational Site, Torino

25100

Pfizer Investigational Site, Brescia

34126

Pfizer Investigational Site, Trieste

36061

Pfizer Investigational Site, Vicenza

37100

Pfizer Investigational Site, Verona

43100

Pfizer Investigational Site, Parma

66016

Pfizer Investigational Site, Guardiagrele (CH)

70100

Pfizer Investigational Site, Bari

95123

Pfizer Investigational Site, Catania

98100

Pfizer Investigational Site, Messina

06012

Pfizer Investigational Site, Città di Castello

00100

Pfizer Investigational Site, Roma

00135

Pfizer Investigational Site, Roma

00137

Pfizer Investigational Site, Roma

07100

Pfizer Investigational Site, Sassari

Unknown

Pfizer Investigational Site, Terni

All Listed Sponsors

lead

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.

INDUSTRY